U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07659626) titled 'Long-term Effects of Acoltremon vs. Control in Dry Eye Disease' on June 12.
Brief Summary: This is a prospective, longitudinal, single-center study designed to evaluate the long-term changes in symptoms and tear production in subjects with dry eye disease. The study is randomized and investigator-masked, with subjects assigned to either the TRYPTYR (Acoltremon ophthalmic solution 0.003%) arm or the control arm (Refresh Classic Preservative-free). The study will be conducted at a single site, with subjects undergoing assessments at baseline and at months 1, 3, 6, 9, and 12.
Study Start Date: July 20
Study Type: OBSERVATIONAL
Condi...